News

FDA approves Jardiance tabs

BY Ryan Chavis

SILVER SPRING, Md. — The Food and Drug Administration announced approval for Jardiance (empagliflozin) tablets, which is to be used as an addition to diet and exercise to improve glycemic control in adults with Type 2 diabetes.

The drug is a sodium glucose co-transporter 2 (SGLT2) inhibitor. It works by blocking the reabsorption of glucose by the kidney, increasing glucose excretion, and lowering blood glucose levels in diabetics who have elevated blood glucose levels, the agency stated.

"Jardiance provides an additional treatment option for the care of patients with type 2 diabetes," said Curtis J. Rosebraugh, M.D., M.P.H., director of the Office of Drug Evaluation II in the FDA’s Center for Drug Evaluation and Research. “It can be used alone or added to existing treatment regimens to control blood sugar levels in the overall management of diabetes.”

Jardiance is distributed by Boehringer Ingelheim Pharmaceuticals.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
News

QS/1 leads the way with EPCS security

BY Ryan Chavis

SPARTANBURG, S.C. — QS/1 is implementing additional security measures to better validate electronic prescriptions for controlled substances, the company announced. QS/1 pharmacies already have access to the new Signature Indicator feature through the company's partnership with Surescripts.

“The Signature Indicator flag has been the most common signing approach by early adopters to EPCS,” said John Frady, QS/1’s market analyst for pharmacy products. “As more doctors and pharmacies use electronic means to prescribe controlled substances, there will be an increase in the use of the even more secure FBCA PKI standard.”

The new security standard is the Federal Bridge Certificate Authority Public Key Infrastructure digital signatures for EPCS transmissions. Surescripts uses this to transmit signatures to verify that they are valid. The network also allows bi-directional exchange of information between hospitals, physicians, payers, pharmacies, labs and more, the company said.

“While other pharmacy management system software providers may have taken an easier route for EPCS security,” Frady added. “QS/1 took the extra steps to use the FBCA PKI standard. When this becomes the preferred method of validation, QS/1 will not have to go through the process of recertification.”
 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
News

Publix posts Q2 sales of $7.5 billion, up 6.6%

BY Michael Johnsen

LAKELAND, Fla. — Publix’ sales for the second quarter of 2014 totaled $7.5 billion, representing a 6.6% increase from last year’s $7 billion. Sales for the second quarter of 2014 were positively impacted 1.3% due to the Easter holiday being in the second quarter of 2014 but in the first quarter of 2013. Comparable-store sales for the second quarter of 2014 increased 6.3%.
 
Publix’ sales for the first half of 2014 were $15.3 billion, a 5.3% increase. Comparable-store sales for the first half of 2014 increased 5.1%.
 
Effective Aug. 1, 2014, Publix’s stock price increased from $32.50 per share to $33.85 per share. Publix stock is not publicly traded and is made available for sale only to current Publix associates and members of its board of directors.
 
“This is our eighth consecutive quarter with an increase in our stock price,” stated Publix CEO Ed Crenshaw. “Our associate owners deserve the credit for continuing to make us a leader in our industry.”
 
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?